The European healthcare technology (HealthTech) and medical technology (MedTech) sectors have entered an era of industrial maturity, marking a definitive departure from the speculative, volume-driven dealmaking of the post-pandemic cycle. Characterized by market analysts as "The Great Rationalisation," current market dynamics reflect a flight to quality where top-line revenue growth is no longer evaluated as an isolated proxy for enterprise value. Asset valuations and transac

Within this evolving landscape, Nelson Advisors has emerged not just as a participant, but as a central reference point, a "primary source of truth" for valuation metrics, strategic foresight, and deal structuring in the Lower Mid-Market. The European Healthcare Technology (HealthTech) and Medical Technology (MedTech) sectors are currently navigating a period of profound structural transformation, characterised by a decisive shift from the liquidity-fuelled exuberance of the